On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Adil Mai

ResearcherPublications, citations & collaboration network

Adil Mai is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Adil Mai have?

ScholarIQindexed works

Adil Mai has 11 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Adil Mai have?

ScholarIQcitation count

Adil Mai has 114 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Adil Mai?

ScholarIQh-index

Adil Mai has an h-index of 2 in OpenAlex.

What is the i10-index of Adil Mai?

ScholarIQi10-index

Adil Mai has an i10-index of 1 in OpenAlex.

What is the ORCID of Adil Mai?

ScholarIQorcid

The ORCID for Adil Mai is on the source record.

What is the OpenAlex record for Adil Mai?

ScholarIQopenalex

The OpenAlex for Adil Mai is on the source record.

What are the most-cited papers on Adil Mai?

ScholarIQmost cited works
Association of rib anomalies and malignancy in childhood
Riccardo Fabian Schumacher, Adil Mai, P. Gutjahr
European Journal of Pediatrics. 1992107 Citations
Dementia Caregivers’ Perspectives on Technology’s Place in Care Practices: Mixed Methods Survey
Julia A. Scott, Emma Cepukenas, MARION HIMES, Kennedy Anderson, Kiren Grewal, Adil Mai, Sheila Yuter, Patricia M. Simone
JMIR Formative Research. 20253 CitationsOPEN ACCESS
Hernie de Bochdaleck étranglée: cause rare d’occlusion intestinale aiguë
Mustapha Iken, Adil Mai, Fatimzahra Choukrad, Meryem Haloua, My Youssef Alaoui Lamrani, Meryem Boubbou, Mustapha Maâroufi, Badreedddine Alami
Pan African Medical Journal. 20192 CitationsOPEN ACCESS
Οbstructive tracheal neοplasm: Primary tracheοbrοnchial nοn-hοdgkin lymphοma
Younes Dkhissi, Badreeddine Alami, Adil Mai, Meryem Halοua, Youssef Alaοui Lamrani, Meryem Bοubbοu, Salma Naimi, M. Serraj, Amal Douida, Hind Fatmi, R. Berrady, B. Amara, Mohammed Chakib Benjelloune, Mustapha Maâroufi
Respiratory Medicine Case Reports. 20201 CitationsOPEN ACCESS
mRECIST Outcomes in EMERALD-1: A Phase 3, Randomized, Placebo-Controlled Study of Transarterial Chemoembolization plus Durvalumab with or without Bevacizumab in Participants with Embolization-Eligible Hepatocellular Carcinoma
Bruno Sangro, Masashi Kudo, Joseph P. Erinjeri, Songbing Qin, Zhenggang Ren, Stephen L. Chan, Yosuke Arai, Jeong Heo, Adil Mai, Felipe Penagos, Yamil Alonso Lopez Chuken, Je‐Hyun Yoon, Won Young Tak, Tanita Suttichaimongkol, Mohamed Bouattour, Shi‐Ming Lin, M. Żotkiewicz, Sajid Ali, G.J. Cohen, Riccardo Lencioni
International Journal of Radiation Oncology*Biology*Physics. 20241 Citations

Related on ScholarIQ

470M+ articles · 14-day free trial